Postibrutinib outcomes in patients with mantle cell lymphoma.

Blood
Peter MartinKristie A Blum

Abstract

Despite unprecedented clinical activity in mantle cell lymphoma (MCL), primary and acquired resistance to ibrutinib is common. The outcomes and ideal management of patients who experience ibrutinib failure are unclear. We performed a retrospective cohort study of all patients with MCL who experienced disease progression while receiving ibrutinib across 15 international sites. Medical records were evaluated for clinical characteristics, pathological and radiological data, and therapies used pre- and postibrutinib. A total of 114 subjects met eligibility criteria. The median number of prior therapies was 3 (range, 0-10). The Mantle Cell Lymphoma International Prognostic Index (MIPI) scores at the start of ibrutinib were low, intermediate, and high in 46%, 31%, and 23% of patients, respectively. Of patients with available data prior to ibrutinib and postibrutinib, 34 of 47 and 11 of 12 had a Ki67 >30%. The median time on ibrutinib was 4.7 months (range 0.7-43.6). The median overall survival (OS) following cessation of ibrutinib was 2.9 months (95% confidence interval [CI], 1.6-4.9). Of the 104 patients with data available, 73 underwent subsequent treatment an average of 0.3 months after stopping ibrutinib with a median OS of 5.8 m...Continue Reading

References

Jul 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christian GisselbrechtNorbert Schmitz
Jun 21, 2013·The New England Journal of Medicine·Michael L WangKristie A Blum
May 30, 2014·The New England Journal of Medicine·Jennifer A WoyachJohn C Byrd
Feb 26, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C Y CheahM L Wang
Jul 21, 2015·Nature Medicine·Wyndham H WilsonLouis M Staudt
Jun 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C Y CheahM L Wang

❮ Previous
Next ❯

Citations

Mar 26, 2016·Blood·Mitchell R Smith
Oct 22, 2016·ACS Chemical Biology·Adam R JohnsonWendy B Young
Aug 20, 2016·Expert Review of Hematology·Saveria CapriaAlessandro Pulsoni
Nov 9, 2016·Critical Reviews in Oncology/hematology·Makhdum AhmedMichael Wang
Nov 9, 2016·Best Practice & Research. Clinical Haematology·Steven T PalsMarcel Spaargaren
Oct 16, 2016·Blood·Caron JacobsonDavid M Weinstock
Nov 30, 2016·Leukemia & Lymphoma·Niklas VogtGeorg Lenz
Apr 14, 2017·Hematology/oncology and Stem Cell Therapy·Jose D Sandoval-SusBijal D Shah
Apr 19, 2017·Nature Communications·Xiaohong ZhaoJianguo Tao
Apr 4, 2017·Bone Marrow Transplantation·M A Kharfan-DabajaM Hamadani
Jul 1, 2017·Expert Opinion on Investigational Drugs·T Seiler, M Dreyling
Jun 27, 2017·Cancer Treatment Reviews·Peter MartinMartin Dreyling
Feb 15, 2018·Targeted Oncology·Valentina RestelliLaura Carrassa
Jan 24, 2018·British Journal of Haematology·Oshrat Hershkovitz-RokahOfer Shpilberg
Nov 28, 2017·Leukemia & Lymphoma·Martin DreylingPier Luigi Zinzani
Oct 19, 2017·Journal of Hematology & Oncology·Michael FichtnerMartin Trepel
May 9, 2018·Expert Review of Hematology·Farrukh T Awan, Wojciech Jurczak
Jan 15, 2019·Expert Review of Clinical Pharmacology·Wojciech JurczakMichael Wang
Dec 10, 2017·Hematology·Peter Martin
Sep 11, 2019·International Journal of Molecular Sciences·Pavel Klener
Aug 30, 2018·Blood·Kami Maddocks
Feb 15, 2019·Blood Advances·Narendranath EpperlaJennifer A Woyach
Mar 13, 2020·Current Medical Research and Opinion·Neerav MongaConstantine Tam
Apr 25, 2020·Leukemia & Lymphoma·Toshiki TeraoKosei Matsue
Jun 5, 2018·Oncotarget·Maria I MerolleMichael L Wang
Apr 24, 2020·Expert Opinion on Investigational Drugs·Clémentine Sarkozy, Vincent Ribrag
May 19, 2020·American Society of Clinical Oncology Educational Book·Jeremy S AbramsonSonali M Smith
Jun 23, 2020·British Journal of Haematology·Victor A ChowAjay K Gopal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
C Y CheahM L Wang
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
R D CassadayA K Gopal
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Parastoo B DahiCraig S Sauter
© 2022 Meta ULC. All rights reserved